Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06171711 · ClinicalTrials.gov registry record · NA

Exposure Therapy Study In Adults With Eating Disorders

A NA study of Anorexia Nervosa and Eating Disorders, sponsored by Milton S. Hershey Medical Center.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06171711 is a NA study of Anorexia Nervosa and Eating Disorders that is actively recruiting participants, run by Milton S. Hershey Medical Center. The registered enrollment target is 30 participants, below the 949-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06171711, a NA study of Anorexia Nervosa and Eating Disorders, is actively recruiting participants, sponsored by Milton S. Hershey Medical Center.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The current proposal will evaluate the feasibility, acceptability, and preliminary efficacy of Exposure Therapy for anorexia nervosa (AN) spectrum disorders (Exp-AN), an innovative treatment rooted in principles of inhibitory learning. Exp-AN will target anxiety about both eating and weight gain by combining in vivo (i.e., in real life) and imaginal (i.e., mental) exposure in novel ways (e.g., eating a feared food while listening to a recording describing fears about weight gain).

Interventions

  • BEHAVIORAL Exposure Therapy

Study Locations (1)

Pennsylvania

  • 905 W Govener Rd - Hershey

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-05-02
Est. Completion 2026-09-30
Phase NA

Sponsor

Milton S. Hershey Medical Center

396 total trials

What the Registry Record Tells You About NCT06171711

The ClinicalTrials.gov registry entry for NCT06171711 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 949-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (97% lower). The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Anorexia Nervosa appearing as the primary indexed condition, and to 1 intervention - of which Exposure Therapy is the first listed.

NCT06171711 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06171711 about?

NCT06171711 is a clinical study titled "Exposure Therapy Study In Adults With Eating Disorders". The current proposal will evaluate the feasibility, acceptability, and preliminary efficacy of Exposure Therapy for anorexia nervosa (AN) spectrum disorders (Exp-AN), an innovative treatment rooted in principles of inhibitory learning. Exp-AN will target anxiety about both eating and weight gain by ...

What is the current status of trial NCT06171711?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-05-02. Estimated completion is 2026-09-30.

What conditions does trial NCT06171711 study?

This clinical trial studies the following conditions: Anorexia Nervosa, Eating Disorders.

What interventions are being tested in trial NCT06171711?

The interventions under investigation include: Exposure Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT06171711?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06171711 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anorexia Nervosa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.